Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.58
Delayed Data
As of Feb 20
 -0.30 / -1.59%
Today’s Change
8.31
Today|||52-Week Range
24.43
-10.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash600.3M322.6M597.3M542.0M
 
 
 
 
 
Short Term Investment Cash-315.8M-277.7M279.9M-55.0M
 
 
 
 
 
Cash & Short Term Investments600.3M322.6M613.3M543.0M
 
 
 
 
 
 
ReceivablesReceivables1.8B2.1B2.7B2.5B
 
 
 
 
 
 
InventoriesInventories883.0M950.6M1.3B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----20.0M8.0M
 
 
 
Other Current Assets587.8M844.1M930.4M948.0M
 
 
 
 
 
Current Assets3.9B4.2B5.5B5.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.1B2.3B2.6B2.5B
 
 
 
 
 
Depreciation-838.8M-977.9M-1.2B-1.2B
 
 
 
 
 
Intangible Assets22.6B20.6B41.6B34.7B
 
 
 
 
 
Other Assets22.8B20.8B41.9B37.0B
 
 
 
 
 
Total Assets28.0B26.4B49.0B43.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable364.6M398.0M433.7M324.0M
 
 
 
 
 
Short Term Debt216.8M7.1M838.5M7.0M
 
 
 
 
 
Accrued Expenses--62.0M364.3M12.0M
 
 
 
 
Other Current Liabilities1.6B2.0B3.6B2.9B
 
 
 
 
 
Other Liabilities2.5B2.7B5.3B3.6B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt17.2B15.3B30.3B29.8B
 
 
 
 
 
Deferred Taxes-2.3B-2.2B-5.7B-5.3B
 
 
 
 
 
Other Liabilities570.9M466.7M1.1B1.0B
 
 
 
 
 
Total Liabilities22.7B20.9B42.9B40.3B
 
 
 
 
 
 
EquityMinority Interest-2.5M-1.3M-3.9M-1.0M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity5.1B5.3B5.9B3.2B
 
 
 
 
 
Total Shareholder Equity5.1B5.3B5.9B3.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding333.0M334.4M342.9M347.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.